Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of BMS-955176 on Ortho Cyclen Pharmacokinetics
NCT02157467Phase 1Completed
- Sponsor
- ViiV Healthcare
- Start
- Jun 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of BMS-955176 in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Primary endpoint: Plasma Ethinyl Estradiol and Norelgestromin concentrations at Day 49. Started Jun 2014; status: completed.
02
Drugs
BMS-955176
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02157467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02157467.